The bypass mechanism theory appears plausible, since studies on cancer cells revealed a direct resistance mechanism to FAK-kinase inhibition by cell surface receptor tyrosine kinases, which can preserve pFAK Y397 activity [87]. Here, PTK2 is linked to cancer.